Apollo Hospitals Powers Into A Buy Range Amid Strong Group Rank

Apollo Hospitals stock has cleared a 8-week, 15% deep Consolidation Base last week. Currently, the stock is trading around just -1% away from its ideal buy price of INR 3284. The stock is worth watching at the current price.

The key trend lines, 10 and 40-week moving averages are at a comfortable position. The current trends of both the averages are upward and the 10-week moving average is trending above the 40-week moving average. The current price of the stock is trading around 7.34% away from the 10-week moving average.

In the last twelve months, Apollo Hospitals has rallied nearly 129.4% as compared to 51.1% for the Nifty500. It has a Relative Strength Rating of 78. We definitely would like to see improvement in the rating. At this point we are taking a step back and focusing on the RS Line.

The Relative Strength Line of the stock is offering a lot of encouragement to investors. It has been making good progress in the recent weeks. The overall long term trend of the line is also trending upward. If Apollo Hospitals can maintain this outperformance, it could make sense as a CANSLIM trade.

Another key part of the jigsaw is institutional sponsorship. Apollo Hospitals has an Accumulation/Distribution Rating of ‘A’. This represents heavy institutional buying over the past 13 weeks. The number of institutional sponsors and shares held by the sponsors, both increased in the last reported quarter.

On the earnings front, Apollo Hospitals has an EPS Rank of 58, which is okay but fails to impress a growth stock investor. The earnings and sales for the stock have grown by 20% and 12%, respectively over the past three years. Its 3-years earnings stability is 34, on a 0 to 99 scale (lower the better). Over the past five years, the earnings and sales for the stock have grown by 1% and 14%, respectively. The 5-years earnings stability is 32. The return on equity for the last reported year is 14%.

The current price of Apollo Hospitals is -3% off from its 52-week high price and 159% above its 52-week low price. The stock belongs to the industry group of Medical-Hospitals, which is exhibiting excellent strength in the current market environment. The current industry group rank is 31.

The stock appears on our idea lists: Trend Template – 5 Months.